한글목차

뼈 생검 시스템 세계 시장 전망은 병원 및 진료소 시장에서의 기회로 인해 유망한 것으로 보입니다. 뼈 생검 시스템 세계 시장은 2025-2031년 5.5%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 뼈 질환의 유병률 증가, 최소침습적 시술에 대한 수요 증가, 첨단 기술 채택 확대 등입니다.

• Lucintel의 예측에 따르면, 유형별로는 일회용 생검침이 예측 기간 동안 높은 성장세를 보일 것으로 예측됩니다.
• 용도별로는 병원이 높은 성장이 예상됩니다.
• 지역별로는 APAC 지역이 예측 기간 동안 가장 높은 성장을 보일 것으로 예측됩니다.

150페이지가 넘는 종합적인 보고서를 통해 비즈니스 의사결정에 도움이 되는 귀중한 인사이트를 얻을 수 있습니다. 다음은 몇 가지 인사이트를 담은 샘플 다이어그램입니다.

뼈 생검 시스템 시장의 새로운 동향

뼈 생검 시스템 산업은 다양한 신흥 트렌드에 의해 주도되고 있으며, 이러한 트렌드는 업계 상황을 변화시키고 기술 혁신을 촉진하고 있습니다. 이러한 추세는 기술 발전, 최소침습적 시술로의 전환, 주요 시장의 규제 환경 변화를 반영하고 있습니다.

• 최소침습적 생검 기술 : 최소침습적 생검 기술은 환자의 불편함과 회복 시간을 최소화할 수 있어 뼈 생검 시스템 시장에서 인기를 끌고 있습니다. CT 유도하 세침생검, 로봇 시스템 등의 시술은 보다 정확하고 정밀도가 높은 것으로 증가 추세에 있습니다. 이러한 개선은 환자 결과 개선, 합병증 감소, 의료 비용 절감으로 이어집니다. 이러한 기술이 병원 및 진료소에 도입되면서 의료의 질이 전반적으로 향상되고, 특히 의료 인프라가 정교한 세계 선진 지역에서 시장 개척의 기폭제가 되고 있습니다.
• 진단기기 기술 개발 : 뼈 생검 시스템 시장은 CT 스캔, MRI, PET 스캔과 같은 영상 진단 기술을 포함한 진단기기의 급속한 발전을 경험하고 있습니다. 이러한 기술은 생검 검사의 정확도와 정밀도를 높여 뼈 질환을 조기에 발견할 수 있게 해줍니다. AI와 머신러닝 알고리즘은 이미지 해석과 의사결정을 개선하고 생검 결과를 최적화하고 있습니다. 진단기기의 개발이 더욱 발전함에 따라 신흥국뿐만 아니라 선진국에서도 채택되어 높은 성장을 견인하고 있습니다.
• 로봇 보조 생검 시스템 : 로봇 보조 생검 시스템은 더 나은 정확성, 유연성, 생검 절차의 제어를 제공함으로써 뼈 생검 시스템 시장을 변화시키고 있습니다. 이러한 시스템은 인위적인 실수 가능성을 최소화하고, 정확한 타겟팅을 통해 최적의 생검 결과를 얻을 수 있는 실시간 이미징을 제공합니다. 이러한 기술은 환자의 안전과 시술의 성공률을 높이기 위해 병원과 진단센터에서 널리 채택되고 있습니다. 로봇 시스템이 저렴해지고 접근성이 높아짐에 따라 전 세계적으로 뼈 생검의 대량 옵션으로 자리 잡을 가능성이 높습니다.
• 맞춤형 의료로의 움직임 : 뼈 생검 시스템 시장에서도 맞춤형 의료로의 움직임이 가속화되고 있습니다. 유전자 프로파일링과 분자 프로파일링의 발전으로 생검 결과는 환자의 개별화된 유전자 프로파일에 따라 치료 전략을 맞춤화하기 위해 활용되고 있습니다. 맞춤형 치료는 뼈 질환과 암을 더 잘 제어할 수 있게 하고, 환자의 회복에 더 나은 기회를 제공합니다. 이러한 추세는 새로운 치료법이나 치료법과 마찬가지로 생검 기술의 혁신에 박차를 가할 것으로 보입니다.
• 신흥 시장에서의 의료 접근성 증가 : 개발도상국, 특히 아시아태평양 및 중남미에서는 의료 접근성이 향상되면서 첨단 진단 기술에 대한 수요가 증가하고 있습니다. 가처분 소득이 증가하고, 헬스케어 인프라가 구축되고 있는 이들 시장은 뼈 생검 시스템에 있어 바람직한 시장입니다. 빠르게 성장하는 헬스케어 시스템의 요구에 적합한 합리적인 가격의 솔루션을 제공하고 시장 점유율을 확대하기 위해 이 시장을 공략하는 기업들의 관심이 높아지고 있습니다. 이러한 추세는 앞으로도 세계 뼈 생검 시스템 시장의 성장을 견인할 것으로 보입니다.

뼈 생검 시스템 시장의 신흥 트렌드는 진단 기법을 변화시키고 시장 개척에 박차를 가하고 있습니다. 최소침습법, AI 통합, 로봇 지원 시스템의 발전으로 진단 정확도가 향상되고, 환자의 회복 시간이 단축되고, 환자의 예후가 개선되고 있습니다. 또한, 맞춤형 의료 트렌드와 신흥 시장의 헬스케어 인프라 성장으로 새로운 전망을 창출하고 있습니다. 이러한 추세는 정확하고 외상이 적은 뼈 생검에 대한 수요 증가를 충족시킬 뿐만 아니라, 향후 시장 성장의 근거를 만들어내고 있습니다.

뼈 생검 시스템 시장의 최근 동향

주로 기술 발전, 신제품 출시, 규제 업데이트로 인해 뼈 생검 시스템 시장에 큰 영향을 미친 최근 몇 가지 사건이 있습니다. 이러한 사건들은 진단의 정확성과 환자 예후를 높이는 데 중점을 두고 있다는 것을 보여줍니다.

• AI 기반 뼈 생검 시스템 출시 : AI를 활용한 뼈 생검 시스템 출시는 업계에서 큰 사건입니다. 이 시스템은 인공지능을 활용하여 이상 발견과 생검 정확도 향상을 돕습니다. AI 알고리즘은 의사가 보다 빠르고 정확하게 영상을 확인할 수 있도록 도와주며, 인위적인 실수 가능성을 최소화합니다. 뼈 생검 시스템에 AI를 접목함으로써 진단 프로세스를 보다 효율적으로 바꾸고 재수술을 최소화할 수 있습니다.
• 새로운 생검 기기의 FDA 승인 : 최근 FDA가 다수의 새로운 뼈 생검 기기를 승인함에 따라 시장이 활성화되고 의료진에게 뼈 질환을 보다 정확하게 진단할 수 있는 최첨단 도구가 제공되고 있습니다. 규제 당국의 혁신적인 기기 승인은 진단 솔루션 강화의 필요성과 뼈 생검 시스템 시장에 대한 신뢰가 높아진 것을 반영합니다.
• 로봇 보조 뼈 생검 시스템의 확대 : 로봇 보조 뼈 생검 시스템은 지난 몇 년 동안 큰 성장을 이루었습니다. 로봇 보조 뼈 생검 시스템은 정확도가 높고 인위적인 실수를 줄일 수 있기 때문에 어려운 경우 뼈 생검의 첫 번째 선택이 되고 있습니다. 이러한 시스템에 대한 수요 증가는 로봇 기술 및 관련 부품의 발전을 촉진하고 있습니다. 병원과 진단센터는 생검 절차를 보다 안전하고 정확하게 수행하기 위해 이러한 시스템을 채택하는 경향이 증가하고 있으며, 이는 전반적인 시장 성장을 가속하고 있습니다.
• CT 유도하 생검 시스템 채택 : CT 유도하 뼈 생검 시스템의 채택은 뼈의 이상을 식별하는 정확도와 효율성이 높아 최근 몇 년 동안 크게 증가하고 있습니다. CT 영상을 통해 의사는 생검침을 정확하게 포인트까지 유도할 수 있어 합병증 위험을 낮추고 진단 결과를 개선할 수 있습니다. 특히 병원과 전문 클리닉에서 이러한 시스템의 사용이 증가하고 있으며, 뼈 생검의 전반적인 성공률과 환자 만족도를 높이고 있습니다.
• 신흥 시장에서의 헬스케어 투자 확대 : 중국, 인도 등 신흥국에서의 헬스케어 투자 확대가 첨단 골생검 시스템 보급에 박차를 가하고 있습니다. 헬스케어에 대한 접근성과 가처분 소득이 증가함에 따라 고품질 진단 기기에 대한 수요가 증가하고 있습니다. 세계 기업들은 이들 시장에 대한 진출을 늘리고 있으며, 이들 시장의 특수한 요구에 대응하기 위해 첨단 생검 시스템을 도입하고 있습니다. 헬스케어 투자 증가는 특히 아시아태평양에서 뼈 생검 시스템 시장의 성장을 지속적으로 촉진할 것으로 예측됩니다.

최근 뼈 생검 시스템 시장의 큰 발전은 기술 혁신의 속도와 고급 진단 기술에 대한 수요 증가를 뒷받침하고 있습니다. AI 기반 시스템, 새로운 기기의 FDA 승인, 로봇 지원 시스템의 확장은 뼈 생검의 미래에 혁명을 일으키고 있습니다. 또한, 신흥 시장에서 세계 시장 침투는 새로운 성장의 길을 열어가고 있습니다. 이러한 발전은 시장이 정확성, 자동화, 접근성을 지속적으로 추구한 결과입니다.

목차

제1장 주요 요약

제2장 세계의 뼈 생검 시스템 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• PESTLE 분석
• 특허 분석
• 규제 환경
• 업계 성장 촉진요인과 과제

제3장 2019년부터 2031년까지 시장 동향과 예측 분석

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 뼈 생검 시스템 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 뼈 생검 시스템 시장 : 유형별
  • 일회용 생검침 : 동향과 예측(2019-2031년)
  • 내구성 있는 생검침 : 동향과 예측(2019-2031년)
• 세계의 뼈 생검 시스템 시장 : 용도별
  • 병원 : 동향과 예측(2019-2031년)
  • 클리닉 : 동향과 예측(2019-2031년)
  • 기타 : 동향과 예측(2019-2031년)

제4장 2019년부터 2031년까지 지역별 시장 동향과 예측 분석

• 지역별 세계 뼈 생검 시스템 시장
• 북미의 뼈 생검 시스템 시장
• 유럽의 뼈 생검 시스템 시장
• 아시아태평양의 뼈 생검 시스템 시장
• 기타 지역뼈 생검 시스템 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업 간의 경쟁 관계
  • 구매자의 교섭력
  • 공급 기업의 교섭력
  • 대체품의 위협
  • 신규 참여업체의 위협

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 뼈 생검 시스템 시장의 유형별 성장 기회
  • 용도별 세계의 뼈 생검 시스템 시장 성장 기회
  • 지역별 세계뼈 생검 시스템 시장 성장 기회
• 세계의 뼈 생검 시스템 시장의 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 뼈 생검 시스템 시장 생산능력 확대
  • 세계의 뼈 생검 시스템 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Stryker
• BD
• Merit Medical Systems
• Argon Medical Devices
• Teleflex
• Instrumed Surgical
• Medax
• Apriomed
• Hengrui Medical
• Amathes

영문목차

The future of the global bone biopsy system market looks promising with opportunities in the hospital and clinic markets. The global bone biopsy system market is expected to grow with a CAGR of 5.5% from 2025 to 2031. The major drivers for this market are the increasing prevalence of bone disorders, the rising demand for minimally invasive procedures, and the growing adoption of advanced technologies.

• Lucintel forecasts that, within the type category, the disposable biopsy needle is expected to witness higher growth over the forecast period.
• Within the application category, the hospital is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Bone Biopsy System Market

The bone biopsy system industry is driven by various emerging trends, which are transforming the landscape and fueling innovation. These trends are reflective of technological advancements, a move towards minimally invasive procedures, and regulatory environment shifts across major markets.

• Minimally Invasive Biopsy Techniques: Minimally invasive biopsy procedures are gaining popularity in the bone biopsy system market because they minimize patient discomfort and recovery time. Procedures such as CT-guided needle biopsy and robotic systems are on the rise, with more precision and accuracy. These improvements lead to improved patient outcomes, fewer complications, and lower healthcare expenses. As these technologies are being embraced by hospitals and clinics, the quality of care gets better overall and catalyzes market growth, particularly in developed parts of the world with sophisticated healthcare infrastructures.
• Technological Developments in Diagnostic Equipment: The bone biopsy systems market is experiencing rapid developments in diagnostic equipment, including imaging technologies like CT scan, MRI, and PET scan. These technologies are enhancing the accuracy and precision of biopsy tests, allowing diseases of the bones to be detected early. AI and machine learning algorithms are also improving image interpretation and decision-making, thereby optimizing biopsy outcomes. With diagnostic equipment progressing further, more will be adopted in both emerging and developed nations, prompting high growth.
• Robotic-Assisted Biopsy Systems: Robot-assisted biopsy systems are transforming the bone biopsy system market by providing better accuracy, flexibility, and control of the biopsy procedure. These systems minimize the chances of human error, provide precise targeting, and provide real-time imaging for optimal biopsy results. Such technologies are being more widely adopted by hospitals and diagnostic centers for enhancing patient safety and procedure success rates. As robotic systems are getting cheaper and more accessible, they are likely to become a mass option for bone biopsies globally.
• Move towards Personalized Medicine: The move towards personalized medicine is picking up pace in the market for bone biopsy systems. With improving genetic and molecular profiling, biopsy outcomes are now being employed to customize treatment strategies according to a patient's individualized genetic profile. Personalized therapies enable better control over bone diseases and cancers, providing a better opportunity for the patient's recovery. This trend is likely to fuel more innovation in biopsy technology, as well as new treatments and therapies.
• Increasing Healthcare Access in Emerging Markets: Developing nations, especially those in the Asia-Pacific and Latin American regions, are experiencing increased access to healthcare and growing demands for sophisticated diagnostic technologies. With rising disposable incomes and advancing healthcare infrastructures, these markets have become desirable for bone biopsy systems. There is an increasing focus by companies to target these markets for tapping their market shares, providing affordable solutions suitable to the needs of rapidly emerging healthcare systems. This trend will continue to drive growth in the global bone biopsy system market.

The emerging trends in the bone biopsy system market are transforming diagnostic procedures and fueling market development. Advancements in minimally invasive methods, AI integration, and robotic-enabled systems are improving diagnostic accuracy, shortening patient recovery time, and enhancing patient outcomes. Additionally, the trend towards personalized medicine and the growing healthcare infrastructure in emerging markets are creating new prospects. These trends not only satisfy the increasing need for accurate and less traumatic bone biopsies but also create grounds for future market growth.

Recent Developments in the Bone Biopsy System Market

There are several recent events that have made a significant impact on the bone biopsy system market, primarily due to technological advancements, new product releases, and regulatory updates. These events indicate the growing emphasis on enhancing diagnostic accuracy and patient outcomes.

• Release of AI-Based Bone Biopsy Systems: The launch of AI-driven bone biopsy systems is a major milestone for the industry. The systems utilize artificial intelligence to help detect irregularities and enhance biopsy accuracy. AI algorithms assist physicians in reviewing images more quickly and accurately, minimizing the chance of human error. Embedding AI in bone biopsy systems will transform the diagnostic process to become more efficient and minimize repeat procedures.
• FDA Approvals for Novel Biopsy Devices: The recent FDA approvals of numerous new bone biopsy devices have stimulated the market, equipping medical professionals with cutting-edge tools to better diagnose diseases of the bone. These products, which come equipped with features like real-time imaging, needle guidance, and enhanced safety procedures, are gaining substantial interest from hospitals and clinics throughout the U.S. The approval of the innovative devices by the regulatory bodies reflects the need for enhanced diagnostic solutions and the growing faith in the bone biopsy system market.
• Expansion of Robotic-Assisted Bone Biopsy Systems: Over the years, robotic-assisted biopsy systems have experienced considerable growth. They offer high accuracy and reduce the role of human error, and therefore, are a first-choice option for bone biopsies in challenging cases. The growth in demand for such systems is pushing the robotic technologies and allied components to advance. Hospitals and diagnostic centers are showing a growing tendency towards adopting these systems to make biopsy procedures safer and more accurate, which is overall driving the market growth.
• Adoption of CT-Guided Biopsy Systems: The uptake of CT-guided bone biopsy systems has grown substantially over the past few years, thanks to their higher accuracy and efficiency in identifying abnormalities in bones. Using CT imaging, physicians are able to navigate biopsy needles with precision to the point, lowering the risk of complications and enhancing diagnostic results. The increasing use of these systems, especially in hospitals and specialized clinics, is driving up the overall success rate of bone biopsies and patient satisfaction.
• Growing Healthcare Investments in Emerging Markets: Growing healthcare investments in emerging economies such as China and India are fueling the uptake of advanced bone biopsy systems. With growing healthcare access and disposable incomes, there is a rising demand for high-quality diagnostic equipment. Global companies are increasing their footprint in these markets, introducing advanced biopsy systems to meet the particular needs of these markets. Increased healthcare investment is anticipated to continue driving growth in the bone biopsy system market, particularly in the Asia-Pacific region.

Recent major advances in the bone biopsy system market underscore the speed of innovation and the growing need for more sophisticated diagnostic technologies. AI-based systems, FDA clearances for new devices, and expansion of robotic-assisted systems are revolutionizing the future of bone biopsies. Moreover, the global market penetration in the emerging markets is creating new avenues for growth. These advancements have been a result of the market's continuous move towards precision, automation, and accessibility.

Strategic Growth Opportunities in the Bone Biopsy System Market

The bone biopsy system market offers different strategic growth opportunities based on various applications. Firms can leverage these opportunities to increase their market share and enrich their portfolios.

• Orthopedic Applications: Orthopedic use of bone biopsy systems continues to be one of the core growth segments, fueled by the rising number of bone disorders, fractures, and diseases such as osteoporosis. As the need for early and correct diagnosis increases, orthopedic clinics and hospitals are converting to high-end biopsy systems to maximize patient care. Players in this segment are likely to experience stable growth as there is a constant requirement for diagnosis in orthopedic medicine.
• Cancer Diagnostics: Bone cancer diagnostics poses an important growth market for the bone biopsy system industry. With increasing rates of bone cancers, most importantly osteosarcoma, there is a growing demand for precise diagnostic systems. Bone biopsy systems with advanced imaging modalities and precision-guided needles are important for diagnosing bone cancers. With growing awareness of early detection, this application will experience significant market growth.
• Infections and Inflammatory Diseases: Bone biopsy systems are critical in the diagnosis of bone infections and inflammatory diseases like osteomyelitis. With infections on the rise and the demand for precise, timely diagnosis increasing, bone biopsy systems with accuracy and less patient discomfort are in greater demand. Hospitals and clinics are increasingly investing in these systems to enhance diagnosis accuracy, making this application a significant growth opportunity for the market.
• Rheumatoid Arthritis and Autoimmune Diseases: The increasing incidence of autoimmune diseases, such as rheumatoid arthritis, is fueling the need for bone biopsy systems. The diseases tend to cause damage and inflammation in the bones, necessitating proper diagnosis and follow-up. Bone biopsy systems play a crucial role in assessing damage severity and treatment plans. Due to the increasing rise in autoimmune diseases worldwide, the demand for biopsy systems within this application is likely to increase significantly.
• Pediatric Applications: Pediatric usage is a new niche market for bone biopsy systems. Early diagnosis of bone ailments such as cancers and genetic disorders is extremely important for children. Pediatric biopsy systems with advanced features for use in smaller bones and less trauma are picking up steam. With enhanced emphasis on child health and more cases of pediatric cancer, this segment offers great growth opportunities for the bone biopsy system market.

Opportunities for strategic growth in the market for bone biopsy systems abound across different applications, most notably in orthopedic care, cancer diagnosis, infection control, autoimmune disease identification, and pediatric healthcare. With the prevalence of bone conditions and cancer on the increase, there is greater demand for sophisticated biopsy systems with precision and efficiency. Focusing on high-demanding applications, businesses can design their solutions to address specific market requirements and yield significant growth opportunities.

Bone Biopsy System Market Driver and Challenges

The bone biopsy system market is driven by diverse technological, economic, and regulatory drivers and challenges that affect market growth. These influences determine the competitive environment and guide product development strategies.

The factors responsible for driving the bone biopsy system market include:

1. Technological Advancements in Biopsy Systems: The ongoing technological development in biopsy systems, including the use of robotics and AI, is propelling market growth by enhancing diagnostic precision and patient outcomes.

2. Rising Incidence of Bone Disorders: With the increasing elderly population globally, the occurrence of bone disorders such as osteoporosis and cancers is on the rise, resulting in increased demand for bone biopsy systems.

3. Rising Awareness and Use of Minimally Invasive Procedures: The transition from traditional invasive diagnostic methods to minimally invasive approaches is spurring demand for bone biopsy systems that cause less pain to patients and provide quicker recovery.

4. Growth of Healthcare Infrastructure in Emerging Markets: With improving healthcare access in developing nations, the rate of adoption of cutting-edge bone biopsy systems is surging, opening up new market opportunities.

5. Supportive Reimbursement Policies: Governments in major markets are providing conducive reimbursement policies for medical equipment, boosting market growth and increasing access to sophisticated diagnostic equipment.

Challenges in the bone biopsy system market are:

1. Exorbitant Price of Sophisticated Systems: Though technology has improved, the cost of sophisticated bone biopsy systems is too high, constituting a major impediment, particularly in cost-sensitive markets such as Asia-Pacific and Africa.

2. Regulatory Challenges: Regulatory processes of approval for products, especially in developing markets, are time-consuming and cumbersome, which slows down the introduction of new products into the market and limits growth prospects.

3. Shortage of Skilled Workforce: The requirement for professionals to manage sophisticated biopsy systems is an issue, especially in developing countries where training and technical skills can be insufficient.

The bone biopsy system market is influenced by technological advancements, rising demand for minimally invasive therapies, and the development of healthcare infrastructure in emerging economies. Despite opportunities for growth, there exist high costs, regulatory barriers, and the requirement for skilled personnel. As these drivers and challenges keep changing, the market will reflect changes to address the rising demands for accurate, efficient, and affordable diagnostics.

List of Bone Biopsy System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bone biopsy system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bone biopsy system companies profiled in this report include-

• Stryker
• BD
• Merit Medical Systems
• Argon Medical Devices
• Teleflex
• Instrumed Surgical
• Medax
• Apriomed
• Hengrui Medical
• Amathes

Bone Biopsy System Market by Segment

The study includes a forecast for the global bone biopsy system market by type, application, and region.

Bone Biopsy System Market by Type [Value from 2019 to 2031]:

• Disposable Biopsy Needle
• Durable Biopsy Needle

Bone Biopsy System Market by Application [Value from 2019 to 2031]:

• Hospitals
• Clinics
• Others

Bone Biopsy System Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Bone Biopsy System Market

The bone biopsy system market has been evolving rapidly due to technological advancements, growing prevalence of bone-related diseases, and increasing demand for minimally invasive diagnostic procedures. Bone biopsies are crucial in diagnosing various bone disorders, including cancers like osteosarcoma and bone infections. Markets in countries such as the United States, China, Germany, India, and Japan are witnessing significant developments, fueled by advancements in diagnostic devices, regulatory clearances, and enhanced healthcare infrastructure. These shifts are due to the growing healthcare market as well as the growing need for less invasive and more precise diagnostic procedures.

• United States: The market for bone biopsy systems in the United States has witnessed considerable growth owing to an increase in bone cancer and orthopedic disorders. Technological developments in robotic-assisted biopsy systems and minimally invasive procedures have been a factor in the growth of the market. In addition, augmented healthcare expenditure and the use of sophisticated diagnostic technologies in hospitals and diagnostic centers are driving the growth. Government policies and FDA approvals for new biopsy systems have established a favorable market scenario for local as well as international players.
• China: The Chinese bone biopsy system market is also growing very fast, helped by its huge population and growing incidence of bone diseases. China's government has placed an emphasis on building healthcare infrastructure and making healthcare more accessible, boosting the demand for diagnostic technology. Nevertheless, despite the market expansion, the issues of affordability, regulatory issues, and inadequate healthcare skills in some areas remain. In spite of all this, there are opportunities for growth in China's expanding middle class and health-conscious population, with foreign firms making a presence in the market.
• Germany: Germany is among the top markets for bone biopsy systems in Europe due to high healthcare standards and innovative technology. The market is supported by robust research and development (R&D) efforts, as well as collaborations between medical device firms and research centers. German hospitals and diagnostic facilities are progressively implementing advanced bone biopsy systems to enhance diagnostic efficacy and minimize procedural-related hazards. Additionally, Germany's strong reimbursement guidelines for medical devices have supported industry growth, and it has become one of the most appealing markets for the bone biopsy market.
• India: The bone biopsy system market in India is growing swiftly, backed by a mix of rising knowledge about bone illnesses and growing numbers of cancer cases. But cost-effective diagnostic solutions and support from the government in the form of regulatory approvals and health insurance schemes are necessary for maintaining growth in the nation. Demand for minimally invasive diagnostic equipment is increasing, particularly in urban regions where access to advanced healthcare is on the rise. Local players are being established to cater to this demand, offering affordable yet good-quality solutions.
• Japan: Japan is experiencing consistent growth in the bone biopsy system market with a high focus on technological development and a strong, well-established health infrastructure. Japan also has the second-highest percentage of aging populations, which leads to an increased incidence of bone diseases such as osteoporosis and cancer of the bone. Japan's healthcare providers are increasingly using robotic-assisted and needle-based biopsy systems to increase patient satisfaction. Additionally, positive reimbursement policies and good emphasis on innovation have made the market competitive, attracting both local and foreign companies.

Features of the Global Bone Biopsy System Market

• Market Size Estimates: Bone biopsy system market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Bone biopsy system market size by type, application, and region in terms of value ($B).
• Regional Analysis: Bone biopsy system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the bone biopsy system market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bone biopsy system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bone biopsy system market by type (disposable biopsy needle and durable biopsy needle), application (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bone Biopsy System Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: PESTLE Analysis
• 2.4: Patent Analysis
• 2.5: Regulatory Environment
• 2.6: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Bone Biopsy System Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Bone Biopsy System Market by Type
  • 3.3.1: Disposable Biopsy Needle: Trends and Forecast (2019 to 2031)
  • 3.3.2: Durable Biopsy Needle: Trends and Forecast (2019 to 2031)
• 3.4: Global Bone Biopsy System Market by Application
  • 3.4.1: Hospitals: Trends and Forecast (2019 to 2031)
  • 3.4.2: Clinics: Trends and Forecast (2019 to 2031)
  • 3.4.3: Others: Trends and Forecast (2019 to 2031)

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Bone Biopsy System Market by Region
• 4.2: North American Bone Biopsy System Market
  • 4.2.1: North American Market by Type: Disposable Biopsy Needle and Durable Biopsy Needle
  • 4.2.2: North American Market by Application: Hospitals, Clinics, and Others
  • 4.2.3: The United States Bone Biopsy System Market
  • 4.2.4: Mexican Bone Biopsy System Market
  • 4.2.5: Canadian Bone Biopsy System Market
• 4.3: European Bone Biopsy System Market
  • 4.3.1: European Market by Type: Disposable Biopsy Needle and Durable Biopsy Needle
  • 4.3.2: European Market by Application: Hospitals, Clinics, and Others
  • 4.3.3: German Bone Biopsy System Market
  • 4.3.4: French Bone Biopsy System Market
  • 4.3.5: Spanish Bone Biopsy System Market
  • 4.3.6: Italian Bone Biopsy System Market
  • 4.3.7: The United Kingdom Bone Biopsy System Market
• 4.4: APAC Bone Biopsy System Market
  • 4.4.1: APAC Market by Type: Disposable Biopsy Needle and Durable Biopsy Needle
  • 4.4.2: APAC Market by Application: Hospitals, Clinics, and Others
  • 4.4.3: Japanese Bone Biopsy System Market
  • 4.4.4: Indian Bone Biopsy System Market
  • 4.4.5: Chinese Bone Biopsy System Market
  • 4.4.6: South Korean Bone Biopsy System Market
  • 4.4.7: Indonesian Bone Biopsy System Market
• 4.5: ROW Bone Biopsy System Market
  • 4.5.1: ROW Market by Type: Disposable Biopsy Needle and Durable Biopsy Needle
  • 4.5.2: ROW Market by Application: Hospitals, Clinics, and Others
  • 4.5.3: Middle Eastern Bone Biopsy System Market
  • 4.5.4: South American Bone Biopsy System Market
  • 4.5.5: African Bone Biopsy System Market

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bone Biopsy System Market by Type
  • 6.1.2: Growth Opportunities for the Global Bone Biopsy System Market by Application
  • 6.1.3: Growth Opportunities for the Global Bone Biopsy System Market by Region
• 6.2: Emerging Trends in the Global Bone Biopsy System Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bone Biopsy System Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bone Biopsy System Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Stryker
  • Company Overview
  • Bone Biopsy System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.2: BD
  • Company Overview
  • Bone Biopsy System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.3: Merit Medical Systems
  • Company Overview
  • Bone Biopsy System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.4: Argon Medical Devices
  • Company Overview
  • Bone Biopsy System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.5: Teleflex
  • Company Overview
  • Bone Biopsy System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.6: Instrumed Surgical
  • Company Overview
  • Bone Biopsy System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.7: Medax
  • Company Overview
  • Bone Biopsy System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.8: Apriomed
  • Company Overview
  • Bone Biopsy System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.9: Hengrui Medical
  • Company Overview
  • Bone Biopsy System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.10: Amathes
  • Company Overview
  • Bone Biopsy System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing